Matthew K Szot Cadrenal Therapeutics, Inc. (CVKD) insider trading activity

CVKD Quotes by TradingView
Shares Held (Direct Ownership) 18.9K
96.21% 3M change
96.21% 12M change
Total Value Held N/A

Matthew K Szot Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2025
SELL
Open market or private sale
$153,145 $14.05 p/Share
10,900 Reduced 36.54%
18,933 Common Stock
Sep 24 2025
SELL
Open market or private sale
$21,000 $14.0 p/Share
1,500 Reduced 4.79%
29,833 Common Stock
Aug 28 2025
SELL
Open market or private sale
$5,600 $14.0 p/Share
400 Reduced 1.26%
31,333 Common Stock
Aug 27 2025
SELL
Open market or private sale
$22,384 $13.99 p/Share
1,600 Reduced 4.8%
31,733 Common Stock
Jan 24 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 9.09%
500,000 Common Stock

Also insider at

SANW
S&W Seed Co Consumer Defensive
EVP Finance & Admin and CFO
INVO
INVO Bioscience, Inc. Healthcare
Director
SNES
SenesTech, Inc. Basic Materials
Director
MKS

Matthew K Szot

Chief Financial Officer
Phoenix, AZ

Track Institutional and Insider Activities on CVKD

Follow Cadrenal Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CVKD shares.

Notify only if

Insider Trading

Get notified when an Cadrenal Therapeutics, Inc. insider buys or sells CVKD shares.

Notify only if

News

Receive news related to Cadrenal Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CVKD